| Serial Number | 87315576 |
| Word Mark | GALXC |
| Filing Date | Friday, January 27, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 22, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 19, 2017 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the term "GALXC" in stylized font with the letter "X" shown in an enlarged image. |
| Goods and Services | Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies |
| Goods and Services | Custom manufacture of oligonucleotides for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders |
| Goods and Services | Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2017 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Dicerna Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Party Name | Dicerna Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02140 |
| Event Date | Event Description |
| Monday, March 22, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 22, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, February 25, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, February 25, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 25, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 19, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 18, 2020 | EXTENSION 5 GRANTED |
| Wednesday, August 12, 2020 | EXTENSION 5 FILED |
| Tuesday, August 18, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, August 12, 2020 | TEAS EXTENSION RECEIVED |
| Thursday, June 4, 2020 | ASSIGNED TO EXAMINER |
| Saturday, February 15, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 13, 2020 | EXTENSION 4 GRANTED |
| Thursday, February 13, 2020 | EXTENSION 4 FILED |
| Thursday, February 13, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, August 14, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 12, 2019 | EXTENSION 3 GRANTED |
| Monday, August 12, 2019 | EXTENSION 3 FILED |
| Monday, August 12, 2019 | TEAS EXTENSION RECEIVED |
| Monday, June 10, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 10, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, January 12, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 10, 2019 | EXTENSION 2 GRANTED |
| Thursday, January 10, 2019 | EXTENSION 2 FILED |
| Thursday, January 10, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, August 15, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 13, 2018 | EXTENSION 1 GRANTED |
| Monday, August 13, 2018 | EXTENSION 1 FILED |
| Monday, August 13, 2018 | TEAS EXTENSION RECEIVED |
| Monday, July 23, 2018 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, February 13, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 19, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 19, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 29, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 15, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 15, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 15, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 14, 2017 | ASSIGNED TO LIE |
| Thursday, November 2, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, August 7, 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 7, 2017 | FINAL REFUSAL E-MAILED |
| Monday, August 7, 2017 | FINAL REFUSAL WRITTEN |
| Friday, July 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 27, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 27, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 25, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 25, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 25, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, April 24, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, January 31, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, January 31, 2017 | NEW APPLICATION ENTERED IN TRAM |